21Vianet 2600Hz 3Com 3GPP 3Leaf 4G 4G licensing 5G Africa Alcatel Shanghai Bell Alcatel-Lucent Alibaba Android antiitrust Apple APT Satellite Arete AT&T auction backbone Baidu Bain bandwidth base station Battery broadband cable CBN CCP censorship Cfius China China brands China FTTH China hi-tech China market China media China Mobile China Mobile Hong Kong China Science China Telecom China Unicom chips Ciena Cisco civil society CNNIC Communist Party convergence copyright CSL cybersecurity Datang drones Egypt Elop Ericsson EU Facebook FDD LTE FDD-LTE feature phones Fiberhome FLAG forecasts Foxconn FTZ Galaxy S3 Google GSMA GTI handset handsets Hisilicon HKBN HKIX HKT HKTV Hong Kong HTC Huawei Hugh Bradlow Hutchison India Infinera Innovation Intel internet investment iOS iPad iPad 2 iPhone IPv6 ITU Japan KDDI KT labour shortage Leadcore low-cost smartphone LTE MAC MAE Mandiant market access Mediatek Meego Miao Wei Microsoft MIIT mobile broadband mobile cloud mobile data mobile security mobile spam mobile TV mobile web Motorola music MVNO MWC national security NDRC New Postcom Nokia Nokia Siemens Nortel NSA NTT DoCoMo OTT Pacnet Panasonic patents PCCW piracy PLA politics Potevio price war private investment Project Loon Qualcomm quantum Reach regulation Reliance Communications Ren Zhengfei Renesys RIM roaming Samsung sanctions Scania Schindler security shanzhai Sharp SKT Skype smartphones Snowden software Sony Ericsson spectrum Spreadtrum standards startups subsea cables subsidies supply chain Symbian tablets Tata Communications TCL TD LTE TD-LTE TD-SCDMA Telstra Trump Twitter urban environment USA US-China vendor financing Vitargent Vodafone New Zealand WAC WCIT Web 2.0 web freedom WeChat WhatsApp Wi-Fi Wikileaks Wimax Windows Mobile WIPO WTO Xi Guohua Xiaolingtong Xinjiang Xoom Youku YTL ZTE

Entries in Hong Kong (1)


Milestone: VC legend backs HK biotech startup

Hong Kong has won acclaim over the years for its kung-fu movies, excellent dining, spectacular skyline and free economy. 

But never for its technology.

So today may eventually be regarded as a modest milestone in its path to becoming a technology hub. It's probably fair to say few Hong Kong citizens are aware that that is a path they are on. In fact, governments over the past 15 years have built science parks and incubators and tipped in growing amounts of R&D cash.

Today's news is that a local startup, Vitargent, has taken on Taiwan-American VC firm W.I. Harper as an investor for an undisclosed amount.

That may sound modest in the extreme, but Harper chairman Peter Liu has enormous cred in the tech investment community. In a career that goes back to 1983 in Taiwan and 1992 in China, his successes include Singapore's Creative Technologies, the inventor of the PC soundcard, and video software firm Divx. Currently, he is an early stage investor in apps search firm Quixey, which has attracted investment from Alibaba and Softbank that values it at $600m. 

Vitargent's back story isn't as long but it's impressive. An incubatee at the Hong  Kong Science Park, it uses fish embryo to test for toxins way more effectively than anyone else. Traditional tests can identify five to ten toxins; it can test for 1,000 (that's transgenic medaka, or Japanese rice fish, glowing fluorescent green, above).

The company has sold its product to international cosmetics and food companies, and according to Liu another major deal is in the pipeline. It has won a brace of awards: The Clinton Global Initiative, the Lee Kwan Yew Global Business Competition, the HSBC Young Entrepreneur Awards. the Hong Kong Awards for Industries.

Vitargent founder Eric Chen says since word leaked of the Harper investment he's had investors beating a path to his door. Although that sounds like startup hyperbole, VCs are herd animals and that's exactly how they behave. The biggest impact from this could be to put Hong Kong finally on the tech investment map.